These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25333799)

  • 41. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.
    Hattar K; Grandel U; Moeller A; Fink L; Iglhaut J; Hartung T; Morath S; Seeger W; Grimminger F; Sibelius U
    Crit Care Med; 2006 Mar; 34(3):835-41. PubMed ID: 16521278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids.
    Seo HS; Nahm MH
    Clin Vaccine Immunol; 2009 Aug; 16(8):1187-95. PubMed ID: 19553557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of anti-kojibiose antibody with the lipoteichoic acids from Streptococcus faecalis and Streptococcus faecium.
    Kessler RE; Duke J; Goldstein IJ
    Infect Immun; 1984 Oct; 46(1):279-81. PubMed ID: 6434429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoteichoic acid synthesis inhibition in combination with antibiotics abrogates growth of multidrug-resistant Enterococcus faecium.
    Paganelli FL; van de Kamer T; Brouwer EC; Leavis HL; Woodford N; Bonten MJ; Willems RJ; Hendrickx AP
    Int J Antimicrob Agents; 2017 Mar; 49(3):355-363. PubMed ID: 28188831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid.
    Mancuso G; Tomasello F; Ofek I; Teti G
    Infect Immun; 1994 Apr; 62(4):1470-3. PubMed ID: 8132355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating microRNA signatures in mice exposed to lipoteichoic acid.
    Hsieh CH; Yang JC; Jeng JC; Chen YC; Lu TH; Tzeng SL; Wu YC; Wu CJ; Rau CS
    J Biomed Sci; 2013 Jan; 20(1):2. PubMed ID: 23286671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor.
    Greenberg JW; Fischer W; Joiner KA
    Infect Immun; 1996 Aug; 64(8):3318-25. PubMed ID: 8757870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice.
    Sigel S; Bunk S; Meergans T; Doninger B; Stich K; Stulnig T; Derfler K; Hoffmann J; Deininger S; von Aulock S; Knapp S
    Eur J Immunol; 2012 Nov; 42(11):2983-9. PubMed ID: 22806614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoteichoic acid synthesis and function in gram-positive bacteria.
    Percy MG; Gründling A
    Annu Rev Microbiol; 2014; 68():81-100. PubMed ID: 24819367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies in rabbits immunized with staphylococcal lipoteichoic acid.
    Aasjord P; Grov A
    Acta Pathol Microbiol Scand B; 1980 Feb; 88(1):53-6. PubMed ID: 6768220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood.
    Bunk S; Sigel S; Metzdorf D; Sharif O; Triantafilou K; Triantafilou M; Hartung T; Knapp S; von Aulock S
    J Immunol; 2010 Sep; 185(6):3708-17. PubMed ID: 20713893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens.
    Gening ML; Maira-Litrán T; Kropec A; Skurnik D; Grout M; Tsvetkov YE; Nifantiev NE; Pier GB
    Infect Immun; 2010 Feb; 78(2):764-72. PubMed ID: 19948836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of synthetic derivatives to determine the minimal active structure of cytokine-inducing lipoteichoic acid.
    Deininger S; Figueroa-Perez I; Sigel S; Stadelmaier A; Schmidt RR; Hartung T; von Aulock S
    Clin Vaccine Immunol; 2007 Dec; 14(12):1629-33. PubMed ID: 17928431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming.
    Brzezińska-Błaszczyk E; Rdzany RS
    Immunol Lett; 2007 Apr; 109(2):138-44. PubMed ID: 17350692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoteichoic acids of lactobacilli inhibit Enterococcus faecalis biofilm formation and disrupt the preformed biofilm.
    Jung S; Park OJ; Kim AR; Ahn KB; Lee D; Kum KY; Yun CH; Han SH
    J Microbiol; 2019 Apr; 57(4):310-315. PubMed ID: 30671742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages.
    Wu BQ; Luo JM; Wang YH; Shi YF; Liu H; Ba JH; Zhang TT
    Clin Exp Med; 2014 May; 14(2):151-60. PubMed ID: 23456570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipoteichoic acid partially contributes to the inflammatory responses to Enterococcus faecalis.
    Baik JE; Ryu YH; Han JY; Im J; Kum KY; Yun CH; Lee K; Han SH
    J Endod; 2008 Aug; 34(8):975-82. PubMed ID: 18634930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to lipoteichoic acid from Staphylococcus aureus. Specificity of murine monoclonal and human antibodies.
    Aasjord P; Haaheim LR
    Acta Pathol Microbiol Immunol Scand C; 1985 Dec; 93(6):245-50. PubMed ID: 2424261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated solid phase synthesis of teichoic acids.
    Hogendorf WF; Meeuwenoord N; Overkleeft HS; Filippov DV; Laverde D; Kropec A; Huebner J; Van der Marel GA; Codée JD
    Chem Commun (Camb); 2011 Aug; 47(31):8961-3. PubMed ID: 21734985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.